The GPR75 Chimeric Recombinant Rabbit Monoclonal Antibody (HDAB0315) is a cutting-edge tool for researchers investigating G protein-coupled receptor 75 (GPR75), a key player in various cellular processes and signaling pathways. This antibody, developed using innovative recombinant technology, is highly specific and sensitive for detecting GPR75 in a variety of samples, particularly human tissues. GPR75 is known for its involvement in diverse functions such as metabolism, cardiovascular regulation, and neuronal signaling, making it a promising target for drug development and therapeutics. Studies have shown that dysregulation of GPR75 is linked to metabolic disorders, cardiovascular diseases, and neurological conditions, highlighting its potential as a diagnostic biomarker and therapeutic target.
Whether studying metabolic pathways, cardiovascular health, or neurological disorders, the GPR75 Chimeric Recombinant Rabbit Monoclonal Antibody provides researchers with a reliable tool for precision detection and analysis of GPR75 protein levels. Its high specificity and sensitivity make it a valuable asset in unraveling the intricate roles of GPR75 in health and disease, paving the way for the development of novel treatments and interventions.
SKU:
HDAB0315
Size:
100 µg
Clonality:
Monoclonal
Clone:
DMC492
Synonyms:
Probable G-protein coupled receptor 75
Applications:
Flow Cyt
Recommended Dilution:
Flow Cyt 1:100
Host Species:
Rabbit
Isotype:
Rabbit/Human Fc chimeric IgG1
Reactivity:
Human
Purification Method:
Purified from cell culture supernatant by affinity chromatography
Formulation:
Powder
Buffer:
1XPBS
Storage:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Usage:
Research use only
Background:
GPR75 is a member of the G protein-coupled receptor family. GPRs are cell surface receptors that activate guanine-nucleotide binding proteins upon the binding of a ligand.[supplied by OMIM, Jul 2002]